BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 18953274)

  • 1. Nesiritide in acute decompensated heart failure: current status and future perspectives.
    Mohammed SF; Korinek J; Chen HH; Burnett JC; Redfield MM
    Rev Cardiovasc Med; 2008; 9(3):151-8. PubMed ID: 18953274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natriuretic peptides for the treatment of acute heart failure: a focus on nesiritide in recent clinical trials.
    Fajardo J; Heywood JT; Patterson JH; Adams K; Chow SL
    Expert Rev Cardiovasc Ther; 2015; 13(7):743-51. PubMed ID: 26028173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefit-risk assessment of nesiritide in the treatment of acute decompensated heart failure.
    Yancy CW
    Drug Saf; 2007; 30(9):765-81. PubMed ID: 17722969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment options for acute decompensated heart failure.
    Southworth MR
    Am J Health Syst Pharm; 2003 Aug; 60 Suppl 4():S7-15. PubMed ID: 12966901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of nesiritide in patients with acute decompensated heart failure.
    DeWald TA; Hernandez AF
    Expert Rev Cardiovasc Ther; 2010 Feb; 8(2):159-69. PubMed ID: 20136602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials.
    Sackner-Bernstein JD; Kowalski M; Fox M; Aaronson K
    JAMA; 2005 Apr; 293(15):1900-5. PubMed ID: 15840865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of recombinant human B-type natriuretic peptide (nesiritide) in the management of acute decompensated heart failure.
    Strain WD
    Int J Clin Pract; 2004 Nov; 58(11):1081-7. PubMed ID: 15605677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nesiritide: a review of its use in acute decompensated heart failure.
    Keating GM; Goa KL
    Drugs; 2003; 63(1):47-70. PubMed ID: 12487622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nesiritide: a reappraisal of efficacy and safety.
    Shah SJ; Teerlink JR
    Expert Opin Pharmacother; 2007 Feb; 8(3):361-9. PubMed ID: 17266470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of nesiritide in patients with decompensated heart failure: a meta-analysis of randomised trials.
    Gong B; Wu Z; Li Z
    BMJ Open; 2016 Jan; 6(1):e008545. PubMed ID: 26739721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dobutamine Therapy is Associated with Worse Clinical Outcomes Compared with Nesiritide Therapy for Acute Decompensated Heart Failure: A Systematic Review and Meta-Analysis.
    Wang XC; Zhu DM; Shan YX
    Am J Cardiovasc Drugs; 2015 Dec; 15(6):429-37. PubMed ID: 26123415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasodilators in the management of acute heart failure.
    Elkayam U; Janmohamed M; Habib M; Hatamizadeh P
    Crit Care Med; 2008 Jan; 36(1 Suppl):S95-105. PubMed ID: 18158484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controversy and conflict in the treatment of acute decompensated heart failure: limited role for nesiritide.
    Noviasky JA
    Pharmacotherapy; 2007 May; 27(5):626-32. PubMed ID: 17461696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure.
    Sackner-Bernstein JD; Skopicki HA; Aaronson KD
    Circulation; 2005 Mar; 111(12):1487-91. PubMed ID: 15781736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nesiritide in acute decompensated heart failure: a pooled analysis of randomized controlled trials.
    Abraham WT; Trupp RJ; Jarjoura D
    Clin Cardiol; 2010 Aug; 33(8):484-9. PubMed ID: 20734445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and economic impact of nesiritide.
    Peacock WF
    Am J Health Syst Pharm; 2003 Aug; 60 Suppl 4():S21-6. PubMed ID: 12966903
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of nesiritide versus milrinone in the treatment of acute decompensated heart failure.
    Lewis DA; Gurram NR; Abraham WT; Akers WS
    Am J Health Syst Pharm; 2003 Aug; 60 Suppl 4():S16-20. PubMed ID: 12966902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nesiritide for the treatment of congestive heart failure.
    Iyengar S; Feldman DS; Trupp R; Abraham WT
    Expert Opin Pharmacother; 2004 Apr; 5(4):901-7. PubMed ID: 15102572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of nesiritide on renal function and mortality in patients suffering from heart failure.
    Dontas ID; Xanthos T; Dontas I; Lelovas P; Papadimitriou L
    Cardiovasc Drugs Ther; 2009 Jun; 23(3):221-33. PubMed ID: 19252976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Science or fiction: use of nesiritide as a first-line agent?
    Noviasky JA; Kelberman M; Whalen KM; Guharoy R; Darko W
    Pharmacotherapy; 2003 Aug; 23(8):1081-3. PubMed ID: 12921256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.